Oncology Institute Net Income Over Time
| TOI Stock | USD 2.45 0.14 5.41% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Oncology Institute Performance and Oncology Institute Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will Oncology introduce new products? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.67) | Revenue Per Share | Quarterly Revenue Growth 0.215 | Return On Assets | Return On Equity |
Investors evaluate Oncology Institute using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Oncology Institute's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Oncology Institute's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Oncology Institute's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Income Analysis
Compare Oncology Institute and related stocks such as Enhabit, Auna SA, and Sonida Senior Living Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EHAB | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 75 M | 111.1 M | (40.4 M) | (80.5 M) | (156.2 M) | (140.6 M) | (133.6 M) |
| AUNA | 22 M | 22 M | 22 M | 22 M | 22 M | 22 M | 22 M | 22 M | 37 M | 72.8 M | (7.3 M) | (27.1 M) | (85.2 M) | (252 M) | 110.7 M | 99.6 M | 104.6 M |
| SNDA | 3.7 M | 3 M | (3.1 M) | (16.5 M) | (24.1 M) | (14.3 M) | (28 M) | (44.2 M) | (53.6 M) | (36 M) | (295.4 M) | 125.6 M | (54.4 M) | (21.1 M) | (2.1 M) | (1.9 M) | (1.9 M) |
| CCRN | 11.5 M | 4.1 M | (42.2 M) | (34.6 M) | (31.8 M) | 4.4 M | 8 M | 37.5 M | (17 M) | (57.7 M) | (13 M) | 132 M | 186 M | 72.6 M | (14.6 M) | (16.7 M) | (15.9 M) |
| EOLS | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (20.1 M) | (4.5 M) | (46.9 M) | (90 M) | (163 M) | (46.8 M) | (74.4 M) | (61.7 M) | (50.4 M) | (45.4 M) | (47.6 M) |
| TMCI | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (3.7 M) | (20.6 M) | (42.8 M) | (49.5 M) | (55.7 M) | (50.2 M) | (47.7 M) |
| KIDS | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (7.9 M) | (6.6 M) | (8.9 M) | (12 M) | (13.7 M) | (32.9 M) | (16.3 M) | 1.3 M | (21 M) | (37.8 M) | (34 M) | (32.3 M) |
| CBLL | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (37.2 M) | (29.5 M) | (40.5 M) | (36.4 M) | (38.2 M) |
| AUTL | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (7.5 M) | (12.6 M) | (19.7 M) | (31.1 M) | (123.8 M) | (142.1 M) | (142.1 M) | (148.8 M) | (208.4 M) | (220.7 M) | (198.6 M) | (188.7 M) |
| AGL | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (60.1 M) | (406.5 M) | (106.6 M) | (262.6 M) | (260.2 M) | (234.1 M) | (245.8 M) |
Oncology Institute and related stocks such as Enhabit, Auna SA, and Sonida Senior Living Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Oncology Institute financial statement analysis. It represents the amount of money remaining after all of Oncology Institute operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Oncology Institute | TOI |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 18000 Studebaker Road, |
| Exchange | NASDAQ Exchange |
USD 2.45
Check out Oncology Institute Performance and Oncology Institute Correlation. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Oncology Institute technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.